Charlottesville, VA – April 21, 2015 – HemoSonics, a medical device company developing a point-of-care diagnostic platform to guide the management of critical bleeding, today announced that an abstract detailing its Quantra Dx™ platform was accepted for the American Association for Clinical Chemistry (AACC) 2015 Annual Meeting. The conference will be help in Atlanta, GA, on July 26 to 30.
Title: Development of A Novel Device to Assess Hemostatic Function from Whole Blood
Authors: Ferrante EA, Blasier KR, Fischer TJ and Viola F
Date: July 28, 2015, 9:30AM
Location: Hall B1